Studies from our laboratory have shown that epigallocatechin-3-gallate, the major polyphenol present in green tea, inhibits ultraviolet (UV)B-exposure-mediated phosphorylation of mitogen-activated protein kinases (MAPKs) (Toxicol. Appl. Pharmacol. 176: 110-117, 2001) and activation of nuclear factor kappa B (NF-jB) (Oncogene 22: 1035(Oncogene 22: -1044(Oncogene 22: , 2003 pathways in normal human epidermal keratinocytes. This study was designed to investigate the relevance of these findings to the in vivo situations in SKH-1 hairless mouse model, which is regarded to have relevance to human situations. SKH-1 hairless mice were topically treated with GTP (5 mg/ 0.2 ml acetone/mouse) and were exposed to UVB 30 min later (180 mJ/cm 2 ). These treatments were repeated every alternate day for 2 weeks, for a total of seven treatments. The animals were killed 24 h after the last UVB exposure. Topical application of GTP resulted in significant decrease in UVB-induced bifold-skin thickness, skin edema and infiltration of leukocytes. Employing Western blot analysis and immunohistochemical studies, we found that GTP resulted in inhibition of UVB-induced: (i) phosphorylation of extracellular-signal-regulated kinases (ERK1/2), (ii) c-Jun N-terminal kinases, and (iii) p38 protein expression. Since NF-jB plays a major role in inflammation and cell proliferation, we assessed the effect of GTP on UVB-mediated modulations in the NF-jB pathway. Our data demonstrated that GTP inhibited UVB-induced: (i) activation of NF-jB, (ii) activation of IKKa, and (iii) phosphorylation and degradation of IjBa. Our data suggest that GTP protects against the adverse effects of UV radiation via modulations in MAPK and NF-jB signaling pathways, and provides molecular basis for the photochemopreventive effect of GTP in an in vivo animal model system.